Expression of the receptor for advanced glycation end products in oligodendrocytes Pages on BioPortfolio:

BioPortfolio - Neuronal Ceroid-Lipofuscinosis - InDepth
Expression of the receptor for advanced glycation end products in oligodendrocytes in response to · oxidative stress. Demyelination is a common
result of ...
http://www.bioportfolio.com/indepth/Neuronal_Ceroid-Lipofusc...

BioPortfolio - TNF publications
18049448, These results suggest that P. acnes stimulates hDF to produce TNF- alpha, which mediates the expression of proMMP-2 through the NF-kappaB pathway.
...
http://www.bioportfolio.com/gene/7124-TNF/publications.html...

Results from other life science and pharmaceutical sites:

Expression of the receptor for advanced glycation ...[J Neurosci ...
2004]; Developmental expression of the receptor for advanced glycation end- products (RAGE) and its response to hyperoxia in the neonatal rat lung. ...
http://www.ncbi.nlm.nih.gov/pubmed/18438937...

Receptor for advanced glycation end products (RAGE) regulates ...
Age- and sex-matched mice were sensitized against oligodendrocyte glycoprotein ...... Expression of receptors for advanced glycation end products in uremia.
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=41...

BioMed Central | Full text | Evidence for a wide extra-astrocytic ...
RAGE: receptor for advanced glycation end products .... Labourdette G, Baudier J : Nuclear expression of S100B in oligodendrocyte progenitor cells correlates ...
http://www.biomedcentral.com/1471-2202/8/2...

Glial S100B Positive Vacuoles In Purkinje Cells: Earliest ...
It is mainly expressed in astrocytes, oligodendrocytes, and Schwann cells. Receptor for advanced glycation end products (RAGE) is a multiligand member of
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21...

1471-2202-8-2 1471-2202 Research article Evidence for a wide extra ...
... of S100B with the receptor for advanced glycation end products (RAGE), ..... 58 59 61 15674151 Nuclear expression of S100B in oligodendrocyte progenitor ...
http://www.biomedcentral.com/content/download/xml/1471-2202-...

Decreased neuronal and increased oligodendroglial ...[J ...
An increased density of oligodendrocytes is observed in the head of the caudate ... Expression of the receptor for advanced glycation end products in ...
http://www.ncbi.nlm.nih.gov/pubmed/1836225...

Testicular development involves the spatiotemporal control of ...
... mouse mesangial cells by advanced glycosylation end products is mediated via .... Regulation and role of PDGF receptor alpha-subunit expression during ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21...

Diabetes, leukoencephalopathy and rage. [Neurobiol Dis. 2006 ...
Increased RAGE (receptor for advanced glycation end products) expression, ... and microglia in grey matter and within oligodendrocytes in white matter. ...
http://www.ncbi.nlm.nih.gov/pubmed/16815028...

Role of p75 Neurotrophin Receptor in the Neurotoxicity by β ...
... receptor 2 in microglia (20), advanced glycation end products receptors .... The expression level of p75NTR in BEp75 cell clones was 3–5-fold higher ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21...

Glucose neurotoxicity : Article : Nature Reviews Neuroscience
Huttunen, H. J., Fages, C. & Rauvala, H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF- kappa ...
http://www.nature.com/nrn/journal/v9/n1/full/nrn2294.html...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.